HUP0002905A2 - 2-{4-[4-(4,5-Diklór-2-metilimidazol-1-il)butil]1-1piperazinil}-5-fluorpirimidin, előállítása és gyógyászati alkalmazása - Google Patents

2-{4-[4-(4,5-Diklór-2-metilimidazol-1-il)butil]1-1piperazinil}-5-fluorpirimidin, előállítása és gyógyászati alkalmazása

Info

Publication number
HUP0002905A2
HUP0002905A2 HU0002905A HUP0002905A HUP0002905A2 HU P0002905 A2 HUP0002905 A2 HU P0002905A2 HU 0002905 A HU0002905 A HU 0002905A HU P0002905 A HUP0002905 A HU P0002905A HU P0002905 A2 HUP0002905 A2 HU P0002905A2
Authority
HU
Hungary
Prior art keywords
methylimidazol
fluoropyrimidine
piperazinyl
dichloro
butyl
Prior art date
Application number
HU0002905A
Other languages
English (en)
Inventor
Jordí Frigola-Constansa
Ramon Merce-Vidal
Original Assignee
Laboratorios Del Dr. Esteve, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Del Dr. Esteve, S.A. filed Critical Laboratorios Del Dr. Esteve, S.A.
Publication of HUP0002905A2 publication Critical patent/HUP0002905A2/hu
Publication of HUP0002905A3 publication Critical patent/HUP0002905A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány az (I) képletű új 2-{4-[4-(4,5-diklór-2-metilimidazol-1-il)-butil]-1-piperazinil}-5-fluor-pirimidinre, ennek gyógyászatilagelfogadható sóira, ilyen vegyületek előállítására, valamint ilyenvegyületeknek a humán és/vagy állatgyógyászatban hasznosítható,különösen szédülés, útibetegség (hányinger), depresszió, szorongás,túlzott gyomorsav-kiválasztás, obszesszív vagy kompulzívrendellenességek, pánikrohamok és alvás közbeni légzési zavarokkezelésére alkalmas gyógyászati készítmények előállításánál valóalkalmazására vonatkozik. Ó
HU0002905A 1997-06-02 1998-05-28 2-{4-[-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use HUP0002905A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9706738A FR2763950B1 (fr) 1997-06-02 1997-06-02 2- {4- [4-(4,5-dichloro-2-methylimidazol-1-yl)butyl] -1- piperazinyl }-5-fluoropyrimidine, sa preparation et son utilisation therapeutique
PCT/EP1998/003190 WO1998055476A1 (fr) 1997-06-02 1998-05-28 2-{4-[4-(4,5-dichloro-2- methylimidazol-1-yl)butyl] -1-piperazinyl}-5-fluoropyrimidine, sa preparation et son utilisation therapeutique

Publications (2)

Publication Number Publication Date
HUP0002905A2 true HUP0002905A2 (hu) 2001-06-28
HUP0002905A3 HUP0002905A3 (en) 2002-01-28

Family

ID=9507480

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002905A HUP0002905A3 (en) 1997-06-02 1998-05-28 2-{4-[-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use

Country Status (22)

Country Link
US (2) US6303608B1 (hu)
EP (1) EP1007522B1 (hu)
JP (1) JP4344890B2 (hu)
KR (1) KR100556559B1 (hu)
CN (1) CN1094491C (hu)
AT (1) ATE228126T1 (hu)
AU (1) AU732722B2 (hu)
BR (1) BR9810240A (hu)
CA (1) CA2292746A1 (hu)
DE (1) DE69809564T2 (hu)
DK (1) DK1007522T3 (hu)
ES (1) ES2149691B1 (hu)
FR (1) FR2763950B1 (hu)
HU (1) HUP0002905A3 (hu)
IL (1) IL133216A0 (hu)
NO (1) NO318757B1 (hu)
NZ (1) NZ501566A (hu)
PL (1) PL190777B1 (hu)
PT (1) PT1007522E (hu)
RU (1) RU2191184C2 (hu)
TR (1) TR199903001T2 (hu)
WO (1) WO1998055476A1 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101152658B1 (ko) * 2009-04-30 2012-06-18 한국과학기술연구원 세로토닌 5-ｈｔ6 길항 활성 효과를 갖는 피페라진 화합물 함유 조성물
RU2660583C1 (ru) * 2017-08-15 2018-07-06 Общество С Ограниченной Ответственностью "Валента - Интеллект" Применение буспирона для лечения функционального головокружения

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2642759B1 (fr) 1989-02-09 1991-05-17 Laboratorios Esteve Sa Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
FR2673628B1 (fr) * 1991-03-07 1993-07-09 Esteve Labor Dr Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles.
FR2712808B1 (fr) 1993-11-25 1996-02-16 Esteve Labor Dr Utilisation des dérivés de 1-{4-[4-aryl(ou hétéroaryl)-1-pipérazinyl]-butyl}-1-H-azole pour la préparation de médicaments destinés au traitement des troubles de la sécrétion gastrique .
FR2742052B1 (fr) * 1995-12-12 1998-04-10 Esteve Labor Dr Utilisation des derives 1-(4-(4-aryl (ou heteroaryl)-1-piper azinyl)-buty)-1h-azole pour le traitement de la depression, des troubles obsessifs compulsifs, l'apnee du sommeil, les dysfonctions sexuelles, l'emese et le mal des transports

Also Published As

Publication number Publication date
ES2149691A1 (es) 2000-11-01
KR100556559B1 (ko) 2006-03-06
WO1998055476A1 (fr) 1998-12-10
ATE228126T1 (de) 2002-12-15
AU7917098A (en) 1998-12-21
DE69809564T2 (de) 2003-07-10
JP4344890B2 (ja) 2009-10-14
NO318757B1 (no) 2005-05-02
DK1007522T3 (da) 2003-03-17
HUP0002905A3 (en) 2002-01-28
RU2191184C2 (ru) 2002-10-20
NO995894L (no) 2000-02-01
CN1261888A (zh) 2000-08-02
DE69809564D1 (de) 2003-01-02
EP1007522B1 (fr) 2002-11-20
BR9810240A (pt) 2000-09-05
IL133216A0 (en) 2001-03-19
NZ501566A (en) 2001-06-29
KR20010013274A (ko) 2001-02-26
PT1007522E (pt) 2003-04-30
NO995894D0 (no) 1999-12-01
CN1094491C (zh) 2002-11-20
CA2292746A1 (fr) 1998-12-10
TR199903001T2 (xx) 2000-07-21
FR2763950B1 (fr) 2002-09-20
US6303608B1 (en) 2001-10-16
JP2002501539A (ja) 2002-01-15
FR2763950A1 (fr) 1998-12-04
AU732722B2 (en) 2001-04-26
ES2149691B1 (es) 2001-05-16
PL337113A1 (en) 2000-07-31
US6346620B1 (en) 2002-02-12
PL190777B1 (pl) 2006-01-31
EP1007522A1 (fr) 2000-06-14

Similar Documents

Publication Publication Date Title
DK1227806T3 (da) Farmaceutisk præparat indeholdende tolterodin og dets anvendelse
DE60128258D1 (de) Indanylderivate zur Behandlung von Atemwegserkrankungen
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
DK0759757T3 (da) Orale, væskeformige alendronatformuleringer
HUP0402217A2 (hu) Platinaszármazékot tartalmazó gyógyászati készítmények
HUP0203325A2 (hu) Biciklusos aminosavak, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
BRPI0111591B8 (pt) composto, composição farmacêutica, e, usos de um composto
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
ATE367387T1 (de) Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden
DE60220055D1 (de) 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
NO962752L (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
HUP9800198A2 (hu) 1-{4-[4-Aril-(vagy -heteroaril)-1-piperazinil]-butil}-1H-azol-származékok alkalmazása gyógyszerkészítmények előállítására
HUP0300863A2 (hu) N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény
BR0009080A (pt) Método de tratamento da apnéia do sono
HUP0204391A2 (en) The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders
WO2003099214A3 (en) Biguanide formulations
HUP0002905A2 (hu) 2-{4-[4-(4,5-Diklór-2-metilimidazol-1-il)butil]1-1piperazinil}-5-fluorpirimidin, előállítása és gyógyászati alkalmazása
NZ334571A (en) Pharmaceutical composition comprising 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy-acetic acid for treating diseases induced by respiratory syncytial virus
ATE404192T1 (de) Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration
RU2004112422A (ru) Роувастатин в преддеменционных состояниях
DE60306503D1 (de) Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
SE0203778D0 (sv) A new oral immediated release dosage form
IL163025A (en) Prucalopride - n - oxides, their preparation and pharmaceutical compositions comprising them
HUP0200129A2 (hu) N-(3'4'-dimetoxi-cinnamoil)-antranilsav alkalmazása szívkoszorúér-műtéttel kapcsolatos cardiovascularis események megelőzésére vagy mérséklésére

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees